Clinical Trials Directory

Trials / Unknown

UnknownNCT01108952

The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
6 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Background: While treatment for pediatric cancer has improved significantly over the past 40 years, the neurotoxic side-effects of the chemotherapy agents themselves are now being recognized. Two drugs suspected of having acute impact on memory performance in children are methotrexate (MTX) and steroids (GCs). In addition, new evidence suggests that this neurotoxicity might actually protect these children from traumatization. Working hypothesis and aims: This project aims to examine the acute impact of MTX and GC chemotherapy on memory performance in children and young adults with cancer, and the subsequent impact on the development of traumatic symptoms. We hypothesize that MTX and GCs will each produce acute declines in memory performance and that children with greater reductions in memory performance will have fewer traumatic symptoms. Methods: The investigators will recruit 45 children being treated with MTX or GCs at Dana Children's Hospital. To determine acute impact on memory, a battery of memory tests will be administered before and after a cycle of MTX and before and after a cycle of GCs. In addition, traumatic symptoms will be assessed at each post-chemotherapy evaluation point Expected results: The investigators expect poorer memory performance after MTX and after GCs and that these performance declines will correlate with lower rates of traumatic symptoms. Importance: The immediate impact of MTX and GCs on memory is not well known, especially in children. In addition, recent findings have led us to hypothesize that chemotherapy-induced deficits in memory function would paradoxically protect these patients from the traumatization often associated with cancer and its treatment. The proposed study will test this novel hypothesis for the first time.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-04-22
Last updated
2010-04-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01108952. Inclusion in this directory is not an endorsement.